ATLANTIC CITY, N.J. Intermittent or even just one day’s use of the painkiller Vioxx could be enough to cause a heart attack, a prominent heart doctor testified today on behalf of a man who is suing drug maker Merck.
Merck debt ratings cut over suits, patents
Fitch Ratings downgraded Merck and Co.'s ratings, citing a series of lawsuits related to Vioxx and the current or pending expiration of patents for several of the drugmaker's top selling drugs.
FDA rejects successor to Vioxx
Merck & Co. says the FDA has turned down its request to market its planned successor to Vioxx, osteoarthritis drug Arcoxia, in the United States.
Vioxx Verdict May Not Be Healthy
Clearly the Texas jury that hit the manufacturer of Vioxx with a $253 million judgment wanted to send a powerful message to the company and the pharmaceutical industry.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved